‘Exciting’ clinical results offer hope for new class of MS therapies
The article discusses the results of a clinical trial that suggest a combination of a diabetes drug and an antihistamine could potentially help repair damage in the nervous system caused by multiple sclerosis (MS). The trial, conducted in Cambridge, found that while the effect was too small for patients to notice a difference after six months, tests did reveal improvements in nerve function. This raises hopes that this approach could help reverse the damage to the protective coatings around nerve fibers, which is a hallmark of MS. The findings are described as "exciting" and offer hope for the development of a new class of therapies for this debilitating neurological condition.
Source: For the complete article, please visit the original source link below.
